BioNet News, Events 19 Jun 2025 Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy Both the quantity and quality of circulating anti-pertussis toxin antibodies are important for protection against severe pertussis. We compared the… Pantitra
BioNet News, Events 12 Jun 2025 Meet BioNet at APS-MCV 2025 | Advancing Pertussis Protection Together Join us at the Asia-Pacific Summit on Medical and Clinical Vaccinology (APS-MCV) during June 14-15, 2025 in Taipei as we… Pantitra
Biotech News 11 Jun 2025 Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy A recent article in Nature Communications describes a nanovaccine platform designed to support the development of personalized cancer vaccines. This approach uses… Pantitra
Biotech News 06 Jun 2025 New mRNA vaccine is more effective and less costly to develop, study finds A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1,… Pantitra
Biotech News 04 Jun 2025 Machine Learning in Immunology: From Epitope Prediction to Smarter Vaccine Design Tracking how well vaccines work is more important than ever—especially with diseases like COVID-19 that keep evolving. But measuring vaccine… Pantitra
